Drug Shortage Report for ONIVYDE

Last updated on 2017-12-07 History
Report ID 28908
Drug Identification Number 02467135
Brand name ONIVYDE
Common or Proper name Irinotecan Liposome for Injection
Company Name SERVIER CANADA INC
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 43MG
Dosage form(s) SUSPENSION
Route of administration INTRAVENOUS
Packaging size Vials of 43g/10ML
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-11-07
Actual start date 2017-11-08
Estimated end date 2017-12-11
Actual end date 2017-12-06
Shortage status Resolved
Updated date 2017-12-07
Company comments For emergency supply, please contact Baxalta customer service at +1 844 423 2090.
Health Canada comments
Contact Address 235 BOUL. ARMAND-FRAPPIER - PARC SCIENTIF. ET DE HAUTE TECH. DE LAVAL
LAVAL, QUEBEC
CANADA H7V 4A7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-12-07 English Compare
v6 2017-12-06 French Compare
v5 2017-12-06 English Compare
v4 2017-11-10 French Compare
v3 2017-11-10 French Compare
v2 2017-11-10 English Compare
v1 2017-11-10 English Compare